Background: Laparoscopic mini-gastric bypass (MGB) is gaining popularity because of favorable weight loss, co-morbidity resolution, simplicity and exit strategies. We evaluated the efficacy of the MGB in %EWL and resolution of type 2 diabetes (T2D) in different age-groups who had different durations of T2D. The successful end-result was set at HbA1c <6.5. Methods: The study is a retrospective a...

Background/Introduction To reduce deleterious effects of C-CPB novel concepts have been developed based on miniaturized cardiopulmonary bypass (Mini-CPB) with closed circuits, low priming volumes and optimized perfusion system. In CABG surgery, it has previously shown that the use of Mini-CPB can reduce systemic inflammation compared to C-CPB [25] and so attenuate the pathologic effects of C-CPB.

INTRODUCTION Mini-gastric bypass (MGB) is a popular bariatric procedure. Its effect on non-alcoholic fatty liver disease (NAFLD), however, has not yet been comprehensively studied. PRESENTATION OF CASE A 57 year-old non-alcoholic female with a body mass index of 42.8kg/m2 underwent MGB without any incident. A concurrent liver biopsy showed an NAFLD activity score (NAS) of 2/8 without fibrosis...

Background: The superiority of minimally invasive aortic valve replacement (AVR) over the standard approach is subject ongoing research. aim this study was to compare outcomes AVR through full sternotomy versus mini-sternotomy.&#x0D; Methods: We included 60 patients who had AVR; 30 underwent J- or T-shaped mini-sternotomy, and a sternotomy. isolated excluded concomitant cardiac procedure, redo ...

OBJECTIVE Unlike gastric banding or sleeve gastrectomy procedures, intestinal bypass procedures, Roux-en-Y gastric bypass in particular, lead to rapid improvements in glycaemia early after surgery. The bypass of the proximal small bowel may have weight loss and even caloric restriction-independent glucose-lowering properties on hepatic insulin sensitivity. In this first human mechanistic study,...

BACKGROUND Laparoscopic gastric bypass is gold-standard for morbid obesity treatment. AIM To describe the results of robotic gastric bypass for morbid obesity patients. METHOD Were operated on 100 morbidly obese patients through totally robotic gastric bypass between 2013 and 2014. They were 83% female. The age ranged from 20 to 65 years old (medium 48,5 years); the body mass index varied b...

BACKGROUND Bariatric surgery is an effective treatment to obtain weight loss in severely obese patients. The feasibility and safety of bariatric robotic surgery is the topic of this review. METHODS A search was performed on PubMed, Cochrane Central Register of Controlled Trials, BioMed Central, and Web of Science. RESULTS Twenty-two studies were included. Anastomotic leak rate was 8.51% in ...

Roux-en-Y gastric bypass is a well-accepted tool for the treatment of obesity and, compared to conventional weight loss methods (eg, diet and exercise) and other weight loss surgeries (eg, gastric banding), it results in considerable weight loss that is maintained long term. Although successful, the mechanisms for weight loss are not completely understood and it is thought that gastrointestinal...

BACKGROUND Morbid obesity is a chronic inflammatory condition due to the production of several cytokines from the adipose tissue. However, what happens with some of these parameters the first days after surgery is unknown. Therefore, the objective of the present study was to determine, through a prospective and descriptive study, the behavior of the C-reactive protein (CRP), the white blood cel...